Listed

Cerenome, Inc.

CNSYNasdaqCIK 1095981HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$411.0k, Q2 FY2026
Operating income−$9.1m, Q2 FY2026
Net income−$9.0m, Q2 FY2026
Cerenome, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported1.7Revenue, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure1.3Revenue, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure1.5Revenue, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure1.4Revenue, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure1.1Revenue, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure1.4Revenue, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure1.4Revenue, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure1.4Revenue, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure1.0Revenue, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure0.4Revenue, Q2 FY2026, three months to 2026-06-30$411.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m2.5Research and development, Q3 FY2023, three months to 2023-09-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure2.8Research and development, Q4 FY2023, three months to 2023-12-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047698. Derived: 12-month figure less the 9-month figure.Report this figure2.8Research and development, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure2.8Research and development, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure2.9Research and development, Q3 FY2024, three months to 2024-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure2.2Research and development, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure1.8Research and development, Q1 FY2025, three months to 2025-03-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure1.2Research and development, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure2.4Research and development, Q3 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure2.9Research and development, Q4 FY2025, three months to 2025-12-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure2.9Research and development, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure4.3Research and development, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Operating income$m(3.3)Operating income, Q3 FY2023, three months to 2023-09-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure(3.9)Operating income, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047698. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Operating income, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure(3.7)Operating income, Q2 FY2024, three months to 2024-06-30−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure(3.8)Operating income, Q3 FY2024, three months to 2024-09-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(3.9)Operating income, Q4 FY2024, three months to 2024-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(3.5)Operating income, Q1 FY2025, three months to 2025-03-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(1.5)Operating income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(4.5)Operating income, Q3 FY2025, three months to 2025-09-30−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(5.7)Operating income, Q4 FY2025, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(7.1)Operating income, Q1 FY2026, three months to 2026-03-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(9.1)Operating income, Q2 FY2026, three months to 2026-06-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$87.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$62.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-05, accession 0000950170-24-025851. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$34.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$27.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$61.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$57.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure0.5Interest expense, Q1 FY2025, three months to 2025-03-31$548.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001193125-26-352444. Derived: 6-month figure less the 3-month figure.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001193125-25-258596. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$17.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Net income$m(3.2)Net income, Q3 FY2023, three months to 2023-09-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure(3.8)Net income, Q4 FY2023, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047698. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Net income, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(2.9)Net income, Q2 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(2.9)Net income, Q3 FY2024, three months to 2024-09-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(3.9)Net income, Q4 FY2024, three months to 2024-12-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(17.4)Net income, Q1 FY2025, three months to 2025-03-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure5.2Net income, Q2 FY2025, three months to 2025-06-30$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(4.4)Net income, Q3 FY2025, three months to 2025-09-30−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(5.7)Net income, Q4 FY2025, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(6.9)Net income, Q1 FY2026, three months to 2026-03-31−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(9.0)Net income, Q2 FY2026, three months to 2026-06-30−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Diluted EPS$ per share(1.00)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figurenot reported(0.75)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure(0.71)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure(0.37)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figurenot reported(29.86)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$29.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(0.16)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(0.04)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figurenot reported(1.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(1.31)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Basic EPS$ per share(1.00)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figurenot reported(0.75)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure(0.45)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure(0.37)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figurenot reported(29.86)Basic EPS, Q1 FY2025, three months to 2025-03-31−$29.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure0.62Basic EPS, Q2 FY2025, three months to 2025-06-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(0.04)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figurenot reported(1.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(1.31)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure

Balance sheet

Cash and equivalents$2.4m, Q2 FY2026
Shareholders' equity$5.5m, Q2 FY2026
Cerenome, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m11.0Cash and equivalents, Q3 FY2023, at 2023-09-30$11.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure8.6Cash and equivalents, FY2023, at 2023-12-31$8.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure2.9Cash and equivalents, Q1 FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure4.9Cash and equivalents, Q2 FY2024, at 2024-06-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure1.2Cash and equivalents, Q3 FY2024, at 2024-09-30$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure0.1Cash and equivalents, FY2024, at 2024-12-31$76.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure9.9Cash and equivalents, Q1 FY2025, at 2025-03-31$9.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure2.2Cash and equivalents, Q2 FY2025, at 2025-06-30$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure13.3Cash and equivalents, Q3 FY2025, at 2025-09-30$13.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure4.3Cash and equivalents, FY2025, at 2025-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure3.0Cash and equivalents, Q1 FY2026, at 2026-03-31$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure2.4Cash and equivalents, Q2 FY2026, at 2026-06-30$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Current assets$m11.6Current assets, Q3 FY2023, at 2023-09-30$11.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure9.8Current assets, FY2023, at 2023-12-31$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure4.2Current assets, Q1 FY2024, at 2024-03-31$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure9.4Current assets, Q2 FY2024, at 2024-06-30$9.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure5.4Current assets, Q3 FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure5.3Current assets, FY2024, at 2024-12-31$5.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure10.9Current assets, Q1 FY2025, at 2025-03-31$10.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure9.2Current assets, Q2 FY2025, at 2025-06-30$9.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure17.6Current assets, Q3 FY2025, at 2025-09-30$17.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure15.2Current assets, FY2025, at 2025-12-31$15.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure18.0Current assets, Q1 FY2026, at 2026-03-31$18.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure11.8Current assets, Q2 FY2026, at 2026-06-30$11.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Total assets$m13.3Total assets, Q3 FY2023, at 2023-09-30$13.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure11.4Total assets, FY2023, at 2023-12-31$11.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure5.6Total assets, Q1 FY2024, at 2024-03-31$5.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure11.2Total assets, Q2 FY2024, at 2024-06-30$11.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure7.0Total assets, Q3 FY2024, at 2024-09-30$7.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure6.6Total assets, FY2024, at 2024-12-31$6.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure12.1Total assets, Q1 FY2025, at 2025-03-31$12.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure10.4Total assets, Q2 FY2025, at 2025-06-30$10.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure18.7Total assets, Q3 FY2025, at 2025-09-30$18.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure16.3Total assets, FY2025, at 2025-12-31$16.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure19.9Total assets, Q1 FY2026, at 2026-03-31$19.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure14.0Total assets, Q2 FY2026, at 2026-06-30$14.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Current liabilities$m10.5Current liabilities, Q3 FY2023, at 2023-09-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure10.7Current liabilities, FY2023, at 2023-12-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure10.4Current liabilities, Q1 FY2024, at 2024-03-31$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure18.8Current liabilities, Q2 FY2024, at 2024-06-30$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure12.1Current liabilities, Q3 FY2024, at 2024-09-30$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure15.6Current liabilities, FY2024, at 2024-12-31$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure10.6Current liabilities, Q1 FY2025, at 2025-03-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure7.3Current liabilities, Q2 FY2025, at 2025-06-30$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure13.6Current liabilities, Q3 FY2025, at 2025-09-30$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure12.3Current liabilities, FY2025, at 2025-12-31$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure8.0Current liabilities, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure8.6Current liabilities, Q2 FY2026, at 2026-06-30$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Total liabilities$m10.7Total liabilities, Q3 FY2023, at 2023-09-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure12.7Total liabilities, FY2023, at 2023-12-31$12.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure10.5Total liabilities, Q1 FY2024, at 2024-03-31$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure18.8Total liabilities, Q2 FY2024, at 2024-06-30$18.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure12.2Total liabilities, Q3 FY2024, at 2024-09-30$12.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure15.6Total liabilities, FY2024, at 2024-12-31$15.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure35.7Total liabilities, Q1 FY2025, at 2025-03-31$35.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure7.3Total liabilities, Q2 FY2025, at 2025-06-30$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure13.6Total liabilities, Q3 FY2025, at 2025-09-30$13.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure12.3Total liabilities, FY2025, at 2025-12-31$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure8.0Total liabilities, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure8.6Total liabilities, Q2 FY2026, at 2026-06-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$m4.3Current portion of debt, Q3 FY2023, at 2023-09-30$4.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure4.0Current portion of debt, FY2023, at 2023-12-31$4.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047698.Report this figure3.6Current portion of debt, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m2.6Shareholders' equity, Q3 FY2023, at 2023-09-30$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure(1.3)Shareholders' equity, FY2023, at 2023-12-31−$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-104258.Report this figure(4.8)Shareholders' equity, Q1 FY2024, at 2024-03-31−$4.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(7.6)Shareholders' equity, Q2 FY2024, at 2024-06-30−$7.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(5.2)Shareholders' equity, Q3 FY2024, at 2024-09-30−$5.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure(8.9)Shareholders' equity, FY2024, at 2024-12-31−$8.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure(23.6)Shareholders' equity, Q1 FY2025, at 2025-03-31−$23.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure3.0Shareholders' equity, Q2 FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure5.1Shareholders' equity, Q3 FY2025, at 2025-09-30$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure4.0Shareholders' equity, FY2025, at 2025-12-31$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure12.0Shareholders' equity, Q1 FY2026, at 2026-03-31$12.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure5.5Shareholders' equity, Q2 FY2026, at 2026-06-30$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure

Cash flow

Operating cash flow−$7.1m, Q2 FY2026
Capital expenditure$499.0k, Q2 FY2026
Cerenome, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,399)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-127014. Derived: 9-month figure less the 6-month figure.Report this figure(1,881)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047698. Derived: 12-month figure less the 9-month figure.Report this figure(4,513)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure(1,150)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108874. Derived: 6-month figure less the 3-month figure.Report this figure(3,680)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001193125-25-258596. Derived: 9-month figure less the 6-month figure.Report this figure(1,211)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(6,172)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(5,798)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-352444. Derived: 6-month figure less the 3-month figure.Report this figure(2,548)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001193125-25-258596. Derived: 9-month figure less the 6-month figure.Report this figure(6,257)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure(6,238)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure(7,132)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-352444. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k10.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-127014. Derived: 9-month figure less the 6-month figure.Report this figure42.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-047698. Derived: 12-month figure less the 9-month figure.Report this figure40.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$40.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure81.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$81.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108874. Derived: 6-month figure less the 3-month figure.Report this figure14.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001193125-25-258596. Derived: 9-month figure less the 6-month figure.Report this figure11.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure7.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001193125-26-352444. Derived: 6-month figure less the 3-month figure.Report this figure27.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001193125-25-258596. Derived: 9-month figure less the 6-month figure.Report this figure30.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104258. Derived: 12-month figure less the 9-month figure.Report this figure818Capital expenditure, Q1 FY2026, three months to 2026-03-31$818.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure499Capital expenditure, Q2 FY2026, three months to 2026-06-30$499.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001193125-26-352444. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)6.90m, Q2 FY2026
Cerenome, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,829,444 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-31, accession 0000950170-23-056844.Report this figure2.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-312,320,017 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060395.Report this figure2.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-302,509,378 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-097091.Report this figure3.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-303,225,351 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-127014.Report this figure4.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-314,321,731 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-30, accession 0000950170-25-079738.Report this figure10.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3010,742,924 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108874.Report this figure7.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-307,855,763 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure0.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31582,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure8.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,366,199 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure107Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30107,428,969 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001193125-25-258596.Report this figure6.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-316,646,049 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226978.Report this figure6.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-306,898,804 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure

Shares outstanding: 7.59mShares outstanding, period not labelled, at 2026-08-057,589,625 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352444.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.